期刊文献+

急性冠脉综合征患者脉搏波传导速度异常的观察 被引量:1

Observation of Pulse Wave Velocity in Patients With Acute Coronary Syndrome
暂未订购
导出
摘要 目的:探讨老年急性冠脉综合征(ACS)患者脉搏波传导速度(PWV)的变化。方法:将142名老年患者分为ACS组和对照组,进行PWV及总胆固醇(TC)、甘油三脂(TG)、低密度胆固醇脂蛋白(LDL-C)、空腹血糖(FBG)、血压和体重指数(BMI)的测量,用聚类分层法对不同PWV及各危险因素分层下两组中PWV的检出率进行统计分析。结果:ACS组PWV在小于1550cm/s亚层中的检出率显著低于对照组,而在1550~1850cm/s和大于1850cm/s亚层中的检出率则高于对照组(P<0.01),PWV是ACS的一个相对独立的危险因子。结论:PWV可以为心血管疾病的预防和诊断提供可靠的信息。 Objective:To investigate the changes of pulse wave velocity (PWV) in old patients with acute coro nary syndrome (ACS). Methods: Hundred and forty two hospitalized patients were divided into ACS group and normal control group. Total cholesterol(TO, triglyceride(TG), low density lipoprotein cholesterol (LDL-C), fasting blood glucose(FBG), blood pressure, body mass index (BMI) and PWV were measured. Cluste〉stratification analysis was used to explore the underlying differences among each tertile of any risk factors. Results:The detection rate of PWV below 1550cm/s was significantly lower in ACS group than that in control group, while PWV was 1550cm/s or higher the detection rate was higher than that in control group (P〈0. 01). PWV is an relatively independent risk factor for ACS. Conclusions.. PWV may provide reliable information in preventing and diagnosing cardiovascular disease.
作者 俞倩 张黎军
出处 《内科急危重症杂志》 2009年第2期78-80,共3页 Journal of Critical Care In Internal Medicine
关键词 急性冠脉综合征 脉搏波传导速度 诊断 Acute coronary syndrome Pulse wave velocity Diagnosis
  • 相关文献

参考文献6

  • 1Yamashina A, Tomiyama H, Arai T, et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res,2003, 26:615.
  • 2Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2000,36: 970.
  • 3Ung Choi C, Bum Park E, Yong Suh S, et al. Impact of aortic stiffness on cardiovascular disease in patients with chest pain: assessment with direct intra-arterial measurement. Am J Hypertens, 2007, 20: 1163.
  • 4吴宗虎,蒲晓群,孙宝贵.内源性一氧化氮合成酶抑制物在冠心病中的表达及意义研究[J].内科急危重症杂志,2006,12(5):216-218. 被引量:5
  • 5Wang X, Keith JC, Struthers AD, et al. Assessment of arterial stiffness, a translational medicine biomarker system for evalua tion of vascular risk. Cardiovasc Ther, 2008, 26:214.
  • 6Francesco MR, Tischa C, Albert F, et al. Arterial stiffness and risk of coronary heart disease and stroke, the Rotterdam Study. Circulation, 2006, 113:657.

二级参考文献12

  • 1Achan V, Broadhead M, Malaki M, et al. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol,2003,23: 1455.
  • 2Boger RH, Lentz SR, Bode-Boger SM, et al. Elevation of asymmetrical dimethylarginine may medicate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans. Clin Sci, 2001,100:161.
  • 3Cooke JP. Asymmetrical dimethylarginine: The Uber marker? Circulation, 2004, 109: 1813.
  • 4Valkonen VP, Paiva H, Salonen IT, et al. Risk of acute coronary events and serum concentration of asymmetrical dirnethylarginine. Lancet,2001,358: 2127.
  • 5Zoccali C, Benedetto FA, Maas R, et al. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thicknessin endstage renal disease. J Am Soc Nephrol, 2002,13: 490.
  • 6Lundman P, Eriksson MJ, Stuhlinger M, et al. Middle-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increase plasma concentrations of asymmetric dimethylarginine. J Am Coll Cardiol, 2001,38:111.
  • 7Zoccali C, Bode-Boger S, Mallamaci F, et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet,2001,358: 2113.
  • 8Nijveldt RJ, Teerlink T, vaa der Hoven B, et al. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr, 2003,22: 23.
  • 9Suwaidi JA, Hamasaki S, Higano ST, et al. Long-term following-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation,2000,101:948.
  • 10Boger RH, Bode-Boger SM. The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol, 2001,41:79.

共引文献4

同被引文献9

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部